A number of clinical trials are currently underway worldwide to assess whether BCG, the old vaccine against tuberculosis, can protect against COVID-19 infection. In this Perspective, we briefly outline the background, the immunological mechanisms (in particular induction of 'innate immune memory' or 'trained immunity'), and further considerations for the potential future use of BCG against viral and other infections
BackgroundThe paper aimed to analyze and evaluate the present literature data on the clinical effect...
Tuberculosis remains one of the most significant human diseases of the developing world, accounting ...
Bacillus Calmette Guerin (BCG) was designed for protecting children against tuberculosis. Also, it c...
The Bacillus Calmette-Guerin vaccine (BCG vaccine) designed to prevent tuberculosis in children has ...
A number of coronavirus disease 2019 (COVID-19) vaccine candidates have shown promising results, but...
Despite controversy over the protective effect of the BCG (Bacille Calmette-Guérin) vaccine in preve...
The COVID-19 pandemic has killed over 400 000 people globally. Ecological evidence indicates that co...
The spread of the novel coronavirus infection (COVID-19) makes the search for new approaches to prev...
Bacillus Calmette-Guérin (BCG) is a live attenuated M. bovis vaccine that was developed about 100 ye...
The Bacillus Calmette–Guérin (BCG) vaccine has been in use for over 100 years. It protects against s...
Trained immunity is a type of non-specific memory-like immune response induced by some pathogens and...
The BCG vaccine is known to impart nonspecific immunological benefits alongside conferring protectio...
COVID-19 is an evolving pandemic and has spread to over 200 countries claiming approximately 3730000...
The Bacillus Calmette–Guerin vaccine is still widely used in the developing world. The vaccination p...
The tuberculosis (TB) vaccine Bacillus Calmette-Guérin (BCG) was introduced 100 years ago, but as it...
BackgroundThe paper aimed to analyze and evaluate the present literature data on the clinical effect...
Tuberculosis remains one of the most significant human diseases of the developing world, accounting ...
Bacillus Calmette Guerin (BCG) was designed for protecting children against tuberculosis. Also, it c...
The Bacillus Calmette-Guerin vaccine (BCG vaccine) designed to prevent tuberculosis in children has ...
A number of coronavirus disease 2019 (COVID-19) vaccine candidates have shown promising results, but...
Despite controversy over the protective effect of the BCG (Bacille Calmette-Guérin) vaccine in preve...
The COVID-19 pandemic has killed over 400 000 people globally. Ecological evidence indicates that co...
The spread of the novel coronavirus infection (COVID-19) makes the search for new approaches to prev...
Bacillus Calmette-Guérin (BCG) is a live attenuated M. bovis vaccine that was developed about 100 ye...
The Bacillus Calmette–Guérin (BCG) vaccine has been in use for over 100 years. It protects against s...
Trained immunity is a type of non-specific memory-like immune response induced by some pathogens and...
The BCG vaccine is known to impart nonspecific immunological benefits alongside conferring protectio...
COVID-19 is an evolving pandemic and has spread to over 200 countries claiming approximately 3730000...
The Bacillus Calmette–Guerin vaccine is still widely used in the developing world. The vaccination p...
The tuberculosis (TB) vaccine Bacillus Calmette-Guérin (BCG) was introduced 100 years ago, but as it...
BackgroundThe paper aimed to analyze and evaluate the present literature data on the clinical effect...
Tuberculosis remains one of the most significant human diseases of the developing world, accounting ...
Bacillus Calmette Guerin (BCG) was designed for protecting children against tuberculosis. Also, it c...